Benjamin Rivnay
Hoofd Techniek/Wetenschap/O&O bij Oxygen Therapy, Inc.
Profiel
Benjamin Rivnay is currently the Chief Scientist at Oxygen Therapy, Inc. He previously worked as the Director of Research & Development at Formatech, Inc., Principal at Neurex Corp., Vice President of Research & Development at ReproSource, Inc., Principal at Procept, Inc., and Chief Scientist at Boston Therapeutics, Inc. Prior to his industry experience, he was a Senior Scientist & Associate Professor at the Weizmann Institute of Science.
Dr. Rivnay received his undergraduate degree from Tel-Aviv University and his doctorate from the Weizmann Institute of Science.
Actieve functies van Benjamin Rivnay
| Bedrijven | Functie | Begin |
|---|---|---|
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Benjamin Rivnay
| Bedrijven | Functie | Einde |
|---|---|---|
Formatech, Inc.
 Formatech, Inc. Pharmaceuticals: MajorHealth Technology Formatech, Inc. develops and manufactures therapeutic products. The firm specializes in contract research & development and aseptic contract manufacturing. It also offers liquid fills, lyophilization, compounding, and development services. The company was founded by Benjamin S. Isaacs in 1993 and is headquartered in Andover, MA. | Hoofd Techniek/Wetenschap/O&O | - |
| NANOMIX CORPORATION | Hoofd Techniek/Wetenschap/O&O | - |
| Weizmann Institute of Science | Corporate Officer/Principal | - |
Neurex Corp.
 Neurex Corp. Pharmaceuticals: MajorHealth Technology Neurex Corporation is a developmental biopharmaceutical company focused on acute care therapeutics for the treatment of diverse neurological and cardiovascular indications. | Corporate Officer/Principal | - |
Procept, Inc.
 Procept, Inc. Pharmaceuticals: MajorHealth Technology Procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. The company is located in San Diego. CA | Corporate Officer/Principal | - |
Opleiding van Benjamin Rivnay
| Weizmann Institute of Science | Doctorate Degree |
| Tel-Aviv University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
ReproSource, Inc.
 ReproSource, Inc. Medical/Nursing ServicesHealth Services ReproSource, Inc. engages in the provision of diagnostic laboratory information for practitioners in the field of reproductive medicine. It offers fertility diagnostics, reporting services, and esoteric and routine testing services catering to in vitro fertilization (IVF) and assisted reproductive technologies (ART) specialists, urologists, and obstetrics and gynecology practitioners. The company was founded by Benjamin Leader, Craig S. Sockol and James W. Winkelman in 2008 and is headquartered in Woburn, MA. | Health Services |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Procept is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system disorders. Procept is developing therapeutics for the treatment of autoimmune disease, organ transplant rejection and infectious diseases, such as AIDS and tuberculosis. The company is located in San Diego. CA | Health Technology |
Neurex Corp.
Neurex Corp. Pharmaceuticals: MajorHealth Technology Neurex Corporation is a developmental biopharmaceutical company focused on acute care therapeutics for the treatment of diverse neurological and cardiovascular indications. | Health Technology |
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
Formatech, Inc.
Formatech, Inc. Pharmaceuticals: MajorHealth Technology Formatech, Inc. develops and manufactures therapeutic products. The firm specializes in contract research & development and aseptic contract manufacturing. It also offers liquid fills, lyophilization, compounding, and development services. The company was founded by Benjamin S. Isaacs in 1993 and is headquartered in Andover, MA. | Health Technology |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Health Technology |
